Johnson & Johnson receives positive CHMP opinion recommending full approval for SIRTURO® for treatment of multidrug-resistant TB

Back to the "HIV and Co-Infections News" list
Tags:

— CHMP recommends Conditional Marketing Authorisation be converted into standard Marketing Authorisation

— Recommendation supported by results from the Phase 3 STREAM Stage 2 study, which show bedaquiline-containing regimens offer significant improvement compared to other available therapies

Read the full press release here.

 

For more TB news, check out the latest edition of the TB Online Weekly Newsletter (#14, 5 May 2024) with the latest TB advocacy and research updates.

The TB Online Weekly Newsletter is brought to you by TB CAB and EATG. Subscribe to the newsletter here.

 

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.